Might olfactory dysfunction be a marker of early Alzheimer's disease?

Lancet

Volumn 355, Issue 9198, 2000, Pages 84-85

  Burns, Alistair ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E;

ALZHEIMER DISEASE; BRAIN ATROPHY; BRAIN CORTEX; CLINICAL FEATURE; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; HUMAN; NEUROPSYCHOLOGICAL TEST; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RISK ASSESSMENT; SENSORY RECEPTOR; SMELLING DISORDER;

EID: 0034620214     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(99)90402-6     Document Type: Note

References (10)

1. Berrios G.E., Brook P. Visual hallucinations and sensory delusions in the elderly. Br J Psychiatry. 144:1984;662-664.
2. Cooper A.F. Deafness and psychiatric illness. Br J Psychiatry. 129:1976;216-226.
3. Serby M., Mohan C., Aryan M., Williams L., Mohs R.G., Davis K.L. Olfactory identification deficits in relatives of Alzheimer's disease patients. Biol Psychiatry. 39:1996;375-377.
4. Serby M., Larson P., Kalstein D. The nature and course of olfactory deficits in Alzheimer's disease. Am J Psychiatry. 148:1991;357-360.
5. Koss E., Weiffenbach J.M., Haxby J.V., Friedland R.P. Olfactory detection and identification performance are dissociated in early Alzheimer's disease. Neurology. 38:1988;1228-1232.
6. Pearson R.C. Cortical connections and the pathology of Alzheimer's disease. Neurodegeneration. 5:1996;429-434.
7. Eichenbaum H., Morton T.H., Potter H., Corkin S. Selective olfaction deficits in case HM. Brain Res Bull. 18:1983;597-600.
8. Graves A.B., Bowen J.D., Rajaram M.S.et al. Impaired olfaction as a marker for cognitive decline. Interaction with apolipoprotein E ε4 status. Neurology. 53:1999;1480-1487.
9. Poirier J., Davignon J., Bouthillier D., Kogan S., Bertrand P., Gauthier S. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet. 342:1993;697-699.
10. Fox N.C., Freeborough P.A., Rossor M.N. Visualisation and quantification of rates of atrophy in Alsheimer's disease. Lancet. 348:1996;94-97.